Latest Insider Transactions at Bria Cell Therapeutics Corp. (BCTX)
This section provides a real-time view of insider transactions for Bria Cell Therapeutics Corp. (BCTX). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of BriaCell Therapeutics Corp. to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of BriaCell Therapeutics Corp.'s insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
May 14
2024
|
Marc Lustig Director |
BUY
Open market or private purchase
|
Indirect |
902,935
+26.2%
|
$1,805,870
$2.21 P/Share
|
|
Dec 28
2022
|
Jamieson Bondarenko Chairman |
BUY
Open market or private purchase
|
Direct |
28,000
+14.15%
|
$112,000
$4.58 P/Share
|
|
Dec 20
2022
|
Jamieson Bondarenko Chairman |
BUY
Open market or private purchase
|
Direct |
22,000
+13.43%
|
$110,000
$5.35 P/Share
|